Related Experiment Video

Updated: Aug 20, 2026

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

Mark J Smyth1, Jeremy Swann, Janice M Kelly

  • 1Cancer Immunology Program, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., 8006, Victoria, Australia. mark.smyth@petermac.org

The Journal of Experimental Medicine
|November 17, 2004
PubMed

Insights

Cytokines like IL-2 and IL-12 use NKG2D ligand recognition to suppress advanced cancers. IL-18 relies on Fas ligand, but combinations enhance both pathways for potent anti-tumor immunity.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cytokine Therapy

Background:

  • Single and combination cytokines show promise in advanced cancer treatment.
  • Tumor cells express NKG2D ligands, but their role in immunotherapy is unexplored.
  • Natural killer (NK) cells are crucial for anti-tumor immunity.

Purpose of the Study:

  • To investigate the role of NKG2D ligand-NKG2D receptor interactions in cytokine-mediated immunotherapy.
  • To determine how different cytokines (IL-2, IL-12, IL-18) utilize distinct immune pathways to suppress tumors.
  • To evaluate the efficacy of cytokine combinations in enhancing anti-tumor responses.

Main Methods:

  • Assessing tumor metastasis suppression by cytokine-stimulated NK cells.
  • Analyzing the dependence of cytokine effects on NKG2D ligand expression and Fas ligand sensitivity.
  • Evaluating perforin-mediated cytotoxicity and Fas ligand-induced apoptosis.

Main Results:

  • IL-2 and IL-12 suppressed metastases via NKG2D ligand recognition and perforin.
  • IL-18-mediated suppression required tumor sensitivity to Fas ligand, independent of NKG2D.
  • Combined IL-2 and IL-18 potently activated both perforin and FasL pathways.

Conclusions:

  • Cytokine choice for immunotherapy can be guided by tumor expression of NKG2D ligands and sensitivity to FasL.
  • Perforin-mediated cytotoxicity is more effective against tumors expressing NKG2D ligands.
  • Targeting the NKG2D pathway with specific cytokines offers a promising strategy for advanced cancer treatment.

More Related Videos

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...